Expression of RNA-binding protein IMP3 (KOC) in benign urothelium and urothelial tumors
Authors:
- Haodong XuHXHaodong Xu
- Betsy O. SpauldingBSBetsy O. Spaulding
- Liang ChengLCLiang Cheng
- Rochelle SimonRSRochelle Simon
- Jorge L. YaoJYJorge L. Yao
- P. Anthony di Sant'AGnesePSP. Anthony di Sant'AGnese
- Patricia A. BournePBPatricia A. Bourne
- Jiaoti HuangJHJiaoti Huang
- 1 August 2008
- journal article
- Published by Elsevier in Human Pathology
- Vol. 39 (8) , 1205-1211
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Molecular Pathways in Invasive Bladder Cancer: New Insights Into Mechanisms, Progression, and Target IdentificationJournal of Clinical Oncology, 2006
- Understanding urothelial carcinoma through cancer pathwaysInternational Journal of Cancer, 2006
- Genetic alterations in urothelial bladder carcinomaCancer, 2006
- P53 as a prognostic marker for bladder cancer: a meta-analysis and reviewThe Lancet Oncology, 2005
- Comprehensive Analysis of CDKN2A Status in Microdissected Urothelial Cell Carcinoma Reveals Potential Haploinsufficiency, a High Frequency of Homozygous Co-deletion and Associations with Clinical PhenotypeClinical Cancer Research, 2005
- Cancer Statistics, 2005CA: A Cancer Journal for Clinicians, 2005
- Rb inactivation promotes genomic instability by uncoupling cell cycle progression from mitotic controlNature, 2004
- Combined Effects of p53, p21, and pRb Expression in the Progression of Bladder Transitional Cell CarcinomaJournal of Clinical Oncology, 2004
- Molecular pathology of non-invasive urothelial carcinomas (part I)Virchows Archiv, 2003
- DNA Methylation and the Mechanisms of CDKN2A Inactivation in Transitional Cell Carcinoma of the Urinary BladderLaboratory Investigation, 2000